OSR Health (OSRHW) Other Non-Current Assets (2024 - 2026)
OSR Health (OSRHW) posted Other Non-Current Assets of $178024.0 for Q1 2026, down 69.25% sequentially from $578917.0 in Q4 2025, and down 49.13% YoY from $349964.0 in Q1 2025.
OSR Health (OSRHW) Other Non-Current Assets (2024 - 2026) Analysis & Trends
OSR Health has reported Other Non-Current Assets for 3 years, with the latest figure at $178024.0 in Q1 2026.
- Quarterly Other Non-Current Assets fell 49.13% year-over-year to $178024.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $178024.0 (down 49.13% YoY) and the FY2025 annual result came in at $578917.0, up 75.83% from the prior year.
- Other Non-Current Assets declined to $178024.0 in Q1 2026 per OSRHW's latest filing, from $578917.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $578917.0 in Q4 2025 and troughed at $170963.0 in Q3 2025.
- A 3-year average of $332921.3 and a median of $339608.0 in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets jumped 75.83% in 2025, then slumped 49.13% in 2026.
- Over 3 years, Other Non-Current Assets stood at $329252.0 in 2024, then surged by 75.83% to $578917.0 in 2025, then slumped by 69.25% to $178024.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $178024.0, $578917.0, and $170963.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 62.96 Mn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 104.44 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 178,024.00 |
| Dec 31, 2025 | 578,917.00 |
| Sep 30, 2025 | 170,963.00 |
| Jun 30, 2025 | 390,408.00 |
| Mar 31, 2025 | 349,964.00 |
| Dec 31, 2024 | 329,252.00 |